ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer

Harun Ozturk, Harun Cingoz, Turan Tufan, Jiekun Yang, Sara J. Adair, Krishna Seshu Tummala, Cem Kuscu, Meric Kinali, Gamze Comertpay, Sarbajeet Nagdas, Bernadette J. Goudreau, Husnu Umit Luleyap, Yagmur Bingul, Timothy B. Ware, Wiliam L. Hwang, Ku lung Hsu, David F. Kashatus, David T. Ting, Navdeep S. Chandel, Nabeel BardeesyTodd W. Bauer, Mazhar Adli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer'. Together they form a unique fingerprint.

INIS

Biochemistry, Genetics and Molecular Biology